key: cord-0133345-wnj3993q authors: Radtke, Andrea J.; Chu, Colin J.; Yaniv, Ziv; Yao, Li; Marr, James; Beuschel, Rebecca T.; Ichise, Hiroshi; Gola, Anita; Kabat, Juraj; Lowekamp, Bradley; Speranza, Emily; Croteau, Joshua; Thakur, Nishant; Jonigk, Danny; Davis, Jeremy; Hernandez, Jonathan M.; Germain, Ronald N. title: IBEX: An open and extensible method for high content multiplex imaging of diverse tissues date: 2021-07-23 journal: nan DOI: nan sha: f08b9ebc186f739f741eae5faac0124bd4af80a8 doc_id: 133345 cord_uid: wnj3993q High content imaging is needed to catalogue the variety of cellular phenotypes and multi-cellular ecosystems present in metazoan tissues. We recently developed Iterative Bleaching Extends multi-pleXity (IBEX), an iterative immunolabeling and chemical bleaching method that enables multiplexed imaging (>65 parameters) in diverse tissues, including human organs relevant for international consortia efforts. IBEX is compatible with over 250 commercially available antibodies, 16 unique fluorophores, and can be easily adopted to different imaging platforms using slides and non-proprietary imaging chambers. The overall protocol consists of iterative cycles of antibody labelling, imaging, and chemical bleaching that can be completed at relatively low cost in 2-5 days by biologists with basic laboratory skills. To support widespread adoption, we provide extensive details on tissue processing, curated lists of validated antibodies, and tissue-specific panels for multiplex imaging. Furthermore, instructions are included on how to automate the method using competitively priced instruments and reagents. Finally, we present a software solution for image alignment that can be executed by individuals without programming experience using open source software and freeware. In summary, IBEX is an open and versatile method that can be readily implemented by academic laboratories and scaled to achieve high content mapping of diverse tissues in support of a Human Reference Atlas or other such applications. Ambitious efforts across multiple consortia, including the Human Cell Atlas (HCA) 1 and Human Biomolecular Atlas Program (HuBMAP) 2 , aim to characterize all cell types in the human body, with the ultimate goal of creating a Human Reference Atlas. While it is impossible to precisely estimate the number of cell types present in the human body, nor the complete list of biomarkers needed to define these unique entities, a recent report identified 1,534 anatomical structures, 622 cell types, and 2,154 biomarkers (632 of which were proteins) in 11 human organs 3 . To provide a spatial context for these complex data, the field needs high content methods that capture the in situ biology of diverse tissues with sufficient coverage depth. Beyond supporting efforts to build a comprehensive map of healthy human tissues, high content imaging is critical for understanding tumor-immune interactions as well as the histopathology of disease. To this end, several multiplexed antibody-based imaging methods have been developed [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] and reviewed [16] [17] [18] . Furthermore, a detailed comparison of these methods can be found in a recent commentary authored by domain experts in the field of spatial proteomics 19 . The majority of these existing methods generate high dimensional datasets through an iterative multistep process (a cycle) that includes: i) immunolabeling with antibodies, ii) image acquisition, and iii) fluorophore inactivation or antibody/chromogen removal. In addition to fluorophore-labelled antibodies, alternative methods such as immunostaining with signal amplification by exchange reaction (Immuno-SABER) 13 and co-detection by indexing (CODEX) 12 employ antibody DNA-barcoding with complementary fluorescent oligonucleotides to collect multiplexed imaging data. Here, fluorescent oligonucleotides are rapidly hybridized and dehybridized to visualize multiple biomarkers in situ. In contrast to these cyclic imaging methods, technologies utilizing metal-conjugated antibodies, such as multiplexed ion beam imaging (MIBI) 14 and imaging mass cytometry (IMC) 15 , probe >40 markers without iterative antibody labeling or removal steps. Although commercialization of CODEX, MIBI, and IMC have enabled deep spatial profiling of tissue samples from large clinical cohorts [20] [21] [22] , these methods are limited to specialized instruments, proprietary reagents, and, for mass spectrometry (MS)-based methods, may require highly trained engineering staff for instrument support. For these reasons, we developed Iterative Bleaching Extends multi-pleXity (IBEX) 23 , a high content imaging method that can be implemented by scientists with basic laboratory skills at relatively low cost. Using commercially available reagents and microscopes, IBEX has been used to spatially characterize complex phenotypes in tissues from experimental animal models 24 as well as clinically relevant human samples 23 . Because antibody validation and panel development can be costly in terms of time and capital 19 , we provide curated lists of antibodies as well as example panels for several tissues. The majority of these resources are optimized for a fixed frozen method of tissue preservation that overcomes the need for antigen retrieval; however, we demonstrate how IBEX can be adopted to formalin-fixed, paraffin embedded (FFPE) tissues. While not documented here, we have previously shown that the basic IBEX workflow enables multiplexed imaging of heavily fixed tissues using Opal fluorophores and is compatible with commercially available oligonucleotide-conjugated antibodies 23 . In this paper, we provide extensive details and representative data for execution of the IBEX protocol along with instructions on how to automate and accelerate data collection using a cost-effective fluidics device and widefield microscope. We additionally provide guidelines for the proper orientation and embedding of tissues to standardize data interpretation across specimens. To facilitate widespread adoption, we present a software solution for image alignment based on a simplified open source interface to the Insight Toolkit (SimpleITK) 25, 26 that can be used by laboratory scientists without programming experience. IBEX expands on earlier work demonstrating the feasibility of using borohydride derivates to bleach fluorescently conjugated antibodies for multiplex imaging 9,27,28 . Bolognesi et al. and others have provided details on the chemistry, fluorophore inactivation, and proteolytic properties of sodium borohydride under their user-defined experimental conditions 9, [27] [28] [29] [30] [31] [32] [33] . For the manual IBEX method described here, we consistently found that 15 minutes of exposure to 1 mg/ml of Lithium Borohydride (LiBH4), a strong reducing agent 34 , eliminated fluorescence signal from the following dyes: Pacific Blue, Alexa Fluor (AF)488, AF532, Phycoerythrin (PE), AF555, eFluor (eF)570, iFluor (iF)594, AF647, eF660, AF680, AF700, and AF750. Other fluorophores (Fluorescein isothiocyanate (FITC)) required a longer incubation time (<30 minutes) or bleaching in the presence of light (Brilliant Violet (BV) BV421 and BV510) for signal loss. Finally, certain fluorophores (Hoechst, JOJO-1, AF594, eF615) maintained their signal over multiple bleaching and imaging cycles (Table S1 ). The new automated IBEX protocol described in this report requires 0.5 mg/ml of LiBH4 treatment for 10 minutes or, in some cases, 20 minutes under constant flow (120 µl/minute) for fluorophore inactivation. The continual exchange of fresh 0.5 mg/ml of LiBH4 (automated), as opposed to a one-time application of 1 mg/ml (manual), enables efficient bleaching at a reduced concentration of LiBH4 while preventing excessive bubble formation within the closed bath chamber, an issue not encountered with the manual method. Tissue-specific panels are designed using antibodies conjugated to LiBH4-sensitive dyes with a LiBH4-resistant dye (usually Hoechst) serving as a fiducial for image alignment across iterative cycles. In our original publication we demonstrated that LiBH4 acts by eliminating fluorescence signal by fluorophore inactivation and not antibody removal 23 . This feature allows for the inclusion of unconjugated primary antibodies in earlier cycles and amplification with fluorescently conjugated secondary antibodies in later cycles as outlined in the automated IBEX panels deposited here (Table S2 ). While both IBEX methods are compatible with indirect immunolabeling, we prefer to use directly labeled antibodies from vendors or conjugated in house using commercial kits. In addition to the points raised by Hickey and colleagues 19 , we recommend purchasing >100 µg of antibody in a suitable format for conjugation; concentration of 1 mg/ml or greater in a buffer without carrier proteins or additives. For panels requiring multiple unconjugated antibodies, we advise placing these antibodies in earlier cycles to avoid unwanted detection by the secondary antibody with directly conjugated antibodies generated in the same host. Furthermore, primary antibodies must be raised in different hosts (rabbit, goat, and rat) versus multiple clones from the same host (3 rabbit clones) when using unconjugated versions with secondary antibody detection. Lastly, the selected secondary antibodies should be highly cross-adsorbed against antibodies from other host species. Here, we provide additional details for pairing antibodies and fluorophores for optimal imaging using manual and automated IBEX methods (Tables S3) . Importantly, the number of parameters that can be imaged per IBEX cycle is dependent on several variables including microscope configuration, tissue autofluorescence, availability of conjugated antibodies, and overall panel design (Tables S2-S3) . The resulting method, IBEX, provides an efficient means for evaluating the spatial landscape of diverse tissues by offering: i) an adhesive that securely attaches tissues to the slide/coverslip surface over multiple fluid exchanges, ii) an abbreviated antibody labelling step to shorten the overall protocol, and iii) an open source image registration workflow. Using the tissue adhesive chrome gelatin alum, IBEX can be performed on the most delicate of tissues without tissue loss or degradation for up to 20 cycles in some cases 23 . Antibody labelling is accelerated using a specialized non-heating microwave for the manual IBEX method (30-45 minutes per cycle) and microscope stage heater at 37°C for the automated IBEX method (1 hour per cycle). The SimpleITK workflow provides registration of images acquired as a 3D tissue stack (manual IBEX) or single 2D z-slice (automated IBEX). We document an easy-touse Imaris XTension (Bitplane) for registration that can be executed by individuals without programming experience. As an additional resource, an overview of costs is provided to aid potential users in writing an instrument grant application or adopting IBEX in their laboratory ( Table S4) . Here, we provide detailed instructions for obtaining high content images from a wide range of tissues using human material as exemplars ( Figure 1 ). The protocol outlines tissue grossing (Steps 1-2), tissue processing (Steps 3-7), manual (Steps 8-38) or automated (Steps 39-77) IBEX imaging, and image alignment with SimpleITK (Steps 78-90). The overall workflow consists of 1) specimen preparation and preservation, 2) IBEX imaging, and 3) image processing that can be executed in 2-5 days or paused after each stage. The target audience for IBEX ranges from academic laboratories desiring an affordable method for highly multiplexed imaging to commercial entities seeking a scalable workflow for characterizing clinical samples. Published studies have evaluated the distribution of immune cells in the livers of prime and target vaccinated animals 24 and visualized diverse stromal populations in human and mouse tissues using multiple markers 23 . Ongoing studies include, but are not limited, to assessing the tumor microenvironment of clinical samples and profiling unique epithelial cell populations present within the human thymus. The additional advancements described here-automation and an easy-to-use image alignment software package-make it an attractive method to gain additional insight into the cellular ecosystems of diverse tissues. In general, sample collection informed by anatomical landmarks (e.g., right axillary lymph node) and histological features (e.g. spatially invariant vasculature) is critical for proper specimen evaluation 35 . For tissue mapping efforts in support of a Human Reference Atlas, precise anatomical locations are required to integrate molecular and spatial data across individuals using a common coordinate framework (CCF) 2, 36 . For these reasons, it is important to record these details and, if possible, discuss with the contributing surgeon, radiologist, and pathologist if unclear. Because the process of autolysis begins immediately after surgical removal of tissues or biopsy, we recommend placing specimens in fixative as soon as possible to prevent tissue degradation and thus preserve immunoreactivity and cytomorphology 35, 37 . The most standard fixative, 10% neutral buffered formalin (4% formaldehyde), fixes tissue at a rate of 1-2 mm per hour at room temperature 37, 38 . To ensure appropriate fixation, tissues should be cut into thin sections (less than 3-5 mm thick), placed in 15-20 fold the volume of fresh fixative, and incubated for a sufficient length of time (12-20 hours) 37, 38 . IBEX is compatible with FFPE samples and detailed protocols for the preparation of such samples are outlined elsewhere 38 . To overcome the technical challenges posed by FFPE samples including epitope loss, the need for antigen retrieval, and high autofluorescence, we utilize a fixative with ~1% (vol/vol) formaldehyde and a gentle detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Using this fixed frozen method, our laboratory has performed multiplexed imaging on a wide range of murine and human tissues [39] [40] [41] [42] [43] [44] [45] [46] . Beyond excellent tissue preservation, this protocol significantly reduces autofluorescence by lysing red blood cells and reducing lipid-containing pigments. Prior to tissue embedding, it is important to properly orient specimens using guidelines established by surgical pathologists 35, 37 . We provide detailed descriptions in the Procedure section for optimal handling of the human bowel, skin, lymph node, and wedge resections (liver, kidney, spleen) as examples (Box 1). We are presently finalizing panels and developing workflows for a greater range of tissues including human and mouse lung, thymus, and various tumors, with our current data showing all these tissues to be compatible with the IBEX protocol. A central tenet of IBEX, and other such methods [4] [5] [6] [7] [8] [9] [11] [12] [13] [14] [15] , is the collection of reproducible multiplexed imaging data using antibodies specific for their intended targets. Recently, members of multiple tissue-mapping consortia including the HCA 1 , HuBMAP 2 , Human Tumor Atlas Network (HTAN) 47 , and Human Protein Atlas 48 , established guidelines for multiplexed antibody-based imaging methods 19 . We refer the reader to this work as it documents how to properly validate antibodies, build and test multiplexed antibody panels, conjugate custom antibody reagents, and overcome tissue autofluorescence. Furthermore, this work provides lists of antibody clones (>400 human; >90 mouse) that have been benchmarked by different users across distinct imaging platforms, including IBEX. An additional resource for qualifying multiplexed imaging panels can be found in a detailed protocol authored by Du and colleagues using tissue-based cyclic immunofluorescence (t-CyCIF) 49 . Of note, this work provides several considerations for characterizing antibody immunolabeling at the pixel-, cell-, and tissue-level and offers guidelines for minimizing artifacts arising from iterative imaging methods. Beyond these technical considerations, skillful panel design requires clarity on the scientific questions to be addressed as well as knowledge of the anatomical structures and cell types present within a given organ. The anatomical structures, cell types, plus biomarkers (ASCT+B) tables-assembled by more than 50 domain experts-are a valuable resource for understanding the tissue microanatomy of 11 human organs (Bone marrow and blood, Brain, Heart, Large intestine, Kidney, Lung, Lymph node, Skin, Spleen, Thymus, Vasculature) with more in the pipeline 3 . Furthermore, one can explore these data with a state-of-the-art visualization tool, aiding in the selection of cell-specific protein biomarkers (BP) to target for multiplexed imaging (https://hubmapconsortium.github.io/ccf-asct-reporter/). Besides these resources, we provide antibodies, multiplexed tissue panels, and several IBEX-specific guidelines to aid in high quality data generation (Tables S1-S3) . Because immunolabeling can vary across tissues, fixation conditions, and the imaging system employed, we recommend careful titration of all antibodies prior to IBEX imaging. Additionally, it is important to test whether novel antibodies are sensitive to LiBH4 before adding them to established multi-cycle panels. This can be determined by comparing immunolabeling in serial sections with or without LiBH4 pre-treatment. For evaluating potential epitope loss resulting from steric hindrance, we compare the spatial distribution patterns of antibody panels acquired serially to ones acquired iteratively via IBEX as we have previously shown 23 . In rare instances, if a particular antibody is thought to be impacted by LiBH4 exposure or cycle order, the affected antibody is moved to an earlier panel. To elaborate on the effect of cycle number on antigenicity, antibodies directed against CD106 (RRID: AB_314561), Chromogranin A (RRID: AB_2892553), and DCAMKL1 (RRID: AB_873537) performed better in cycle 1 than in cycles 10, 7, and 5, respectively, in a 48-plex human thymus imaging panel (unpublished work). This issue impacts <2% of IBEX characterized antibodies versus the 12% 6 to 15-20% 8 of antibodies shown to be affected by cycle number in methods employing hydrogen peroxide (H2O2) as a fluorophore inactivation agent. However, we have observed diminished signal intensity with AF700-conjugated antibodies placed in later cycles (after cycle 4) as opposed to the same clone conjugated to other fluorophores. This, coupled with the limited availability of AF700conjugated antibodies, reduces the number of parameters that can be robustly imaged over successive cycles. Given the importance of fluorophore conjugate on antibody performance, we provide guidelines for antibody-fluorophore pairing specific to manual and automated modes of IBEX (Tables S3) . The manual IBEX method is compatible with a wide range of imaging substrates and can be easily adapted to diverse systems including upright and inverted microscopes. We have performed IBEX on upright microscopes with tissues adhered to slides. However, we prefer using an inverted microscope with a chambered coverglass as it eliminates the need for coverslip removal between cycles. When preparing chambered coverglass samples, it is important to place the tissue in the center of the well to prevent any damage to microscope objectives. To ensure a uniform focal plane and secure adherence, the tissue must be carefully flattened onto the glass surface with a paintbrush (Extended Data Figure 1a ). For 20-30 µm tissue sections, we utilize the PELCO BioWave Pro 36500-230 microwave for antibody labelling; however, comparable immunolabeling is observed for thin (~5-10 µm) tissue sections incubated for 1 hour at 37°C. Before fluorophore inactivation with LiBH4, we extensively wash the sample (3 exchanges of 1 ml of PBS) to remove mounting media. We additionally wait until small bubbles form in the LiBH4 solution, typically 10 minutes after dissolving in water, before adding to the samples. Small bubbles routinely form on the tissue during the 15-minute incubation of LiBH4 (Extended Data Figure 1b ). Because the manual IBEX method involves removing the sample from the microscope stage for iterative rounds of fluorophore inactivation and immunolabeling, careful attention must be paid to the alignment of images acquired over distinct cycles. We achieve this by matching shared landmarks, such as distinct nuclear morphology, in the first z-slice (Begin) and last z-slice (End) across the different image volumes (Extended Data Figure 1c ). Manual execution is required in instances where a fluidics device is not available or compatible with existing instrumentation. Indeed, the IBEX method was initially developed using an advanced confocal instrument equipped with a 405 nm laser and a white light laser source producing a continuous spectral output between 470 and 670 nm. This system confers several advantages over conventional widefield microscopes including the ability to image more markers per cycle and the acquisition of fully resolved 3D z-stacks. However, this instrument is presently incompatible with the automated workflow described below. In addition to overcoming instrument limitations, the manual method provides users a means to acquire highly multiplexed images under experimental conditions not amenable to IBEX automation, e.g. access to pre-cut FFPE slides only. To enable widespread adoption and higher throughput, we designed an automated workflow that could be easily implemented by most laboratories and possessed an economical equipment footprint (Figure 2a -c, Extended Data Figure 2 ). We achieved this goal by integrating an inverted widefield microscope (Leica Microsystems THUNDER imaging system) and a compact fluidics device (Fluigent ARIA). Our selection of an imager was based on the following technical specifications: i) ability to image multiple fluorophores per cycle, ii) stable multi-hour (>16 hours) acquisitions with pixel-pixel alignment across imaging cycles, iii) external triggering capabilities to interface with fluidics device, and iv) capture of multiple regions of interest with tiling in 2D and 3D. Of note, the THUNDER computational clearing and adaptive deconvolution software provides confocal quality images (based on contrast) in a fraction of the time and cost of traditional laser scanning confocal microscopes, making it particularly attractive for IBEX automation. With regards to the fluidics device, we required an instrument that was able to send and receive Transistor-Transistor Logic (TTL) pulses while supporting delivery of multiple solutions. The Fluigent ARIA possesses 10 reservoirs and typical experiments utilize the following configuration: i) LiBH4 in Reservoir 1, ii) Hoechst labelling in Reservoir 2, iii) Antibody panels in Reservoirs 3-8, and iv) PBS wash in Reservoir 10 with an empty Reservoir 9. However, it is possible to deliver 7 unique antibody solutions with 4 fluorophores per cycle to achieve a 29-parameter dataset (7 cycles of 4 fluorophores per cycle plus Hoechst as a fiducial) in one execution of the program. Samples are prepared using coated 22 mm square coverslips and the RC-21B closed bath imaging chamber supplied by Warner Instruments (Figure 2b , Extended Data Figure 2 ). In addition to supporting linear solution flow, the closed bath system provides a large viewing area with a total bath volume of 358 µl, greatly reducing antibody labelling costs. Together, the protocol steps of immunolabeling, imaging, and fluorophore inactivation (Figure 2c ) can be automated using commercially available instruments and reagents to obtain highly multiplexed images. Both versions of IBEX yield a series of images that are collected separately as either 3D image stacks (manual) or 2D single z-slices (automated). Using SimpleITK, we developed an intensity-based image alignment protocol to register 2D and 3D IBEX-generated images. In our initial report, we improved upon existing algorithms 50,51 by providing a workflow capable of aligning large datasets (>260 GB) that additionally offers flexibility with regard to the fiducial used for registration 23 . To assess the quality of image alignment, a cross correlation matrix may be generated using a marker channel that is repeated across the cycles. Here, we document a user-friendly solution for image alignment by developing an executable that is compatible with Imaris, a commercial microscopy analysis software suite in worldwide use. Through the freeware Imaris Viewer and SimpleITK Imaris XTension, biologists without programming experience can obtain cell-cell registration across x-y-z dimensions from iterative cycles of IBEX at limited cost. IBEX has several advantages over existing multiplexed antibody-based imaging methods including its i) open and flexible nature, ii) capacity to utilize different imaging platforms, iii) short immunolabeling and bleaching time, iv) unrestricted compatibility with hundreds of commercial antibodies conjugated to diverse fluorophores, and v) simple implementation by biologists in standard laboratory environments. To date, we have demonstrated that 12 fluorophores, corresponding to 8 distinct imaging channels, can be inactivated within 10-20 minutes of LiBH4 treatment alone. In contrast, methods employing H2O2 for fluorophore inactivation are limited to 7 fluorophores, representing 3 imaging channels, and require 1 hour in the presence of light for signal elimination 8 . Thus, the ability to inactivate diverse fluorophores in a short period of time is a significant advantage over existing iterative imaging methods. Importantly, treatment of fixed frozen tissue sections with LiBH4 does not result in tissue loss as we previously found for H2O2 23 . The work outlined here and previously 23 offer a resource to the field of antibody-based imaging by providing exhaustive lists of validated reagents and approved panels for mouse and human tissues. It is our intent to enable high quality data generation while defraying the substantial cost, many thousands of US dollars for a 50-plex panel, and time, around 6 months, to develop equivalent panels de novo 19 . The primary limitation of the original IBEX method was that it required manual execution; however, we now have an affordable automated solution for high content imaging (Table S4) . Presently, the thickness of tissue that can be imaged is restricted to <50 µm due to local tissue warping and distortion across iterative cycles. Beyond increasing the tissue volume that can be acquired (>400 µm), future improvements include custom fabrication of imaging chambers >22 mm 2 to enable automated acquisition of larger tissue areas including whole slide scans and tissue microarrays. We are actively working on methods that increase the number of parameters that can be imaged in a single IBEX cycle by employing additional IBEX compatible fluorophores and confocal microscopes equipped with advanced detectors and extended spectral outputs of 440-790 nm. While high numerical aperture (NA) objectives (40x, 1.3) have been shown to work well in IBEX imaging, we have not yet carefully tested higher magnification (63x, 100x) or higher NA (1.4) objectives for resolving subcellular structures. o Human Tissue ▪ Human tissue was obtained on a NIH Institutional Review Board (IRB)approved protocol (13-C-0076) at the time of risk-reducing surgery performed as a consequence of germline genetic mutation(s). All tissue procured, which included biopsies of lymph nodes, skin, spleen, liver and jejunum, was grossly normal as determined by the operative surgeon and histopathologically normal as determined by a boardcertified pathologist. Of note, all tissue was obtained within twenty minutes of skin incision given our observation of neutrophil infiltrate with prolonged (>1 hour) procedures. Human kidney samples were collected from patients undergoing elective renal surgery at Hannover Medical School. Samples were enrolled in this study after histologic assessment only after completion of routine diagnostics and written consent approved by the local ethics committee of Hannover Medical School (ethics-vote number: 3381-16, 2893-15, 1741-13). ▪ Caution: Any experiments involving human tissues must conform to relevant institutional and national regulations. All procedures described in this protocol were approved by an IRB. • Manual and Automated IBEX Tissue grossing Timing: 2-3 hours, depending on the number and type of samples 1) Survey the organ specimens for distinct anatomical landmarks that may aid in tissue orientation, and, whenever possible, preserve these metadata. If biopsies are assessed, clinical imaging data (Computerized Tomography (CT) scan, ultrasound) of the biopsy procedure is helpful. 2) Prepare samples with dissecting tools (scalpel, forceps, scissors) on a dissecting mat or other clean, fiber-free surface. For small samples, a stereomicroscope and illuminator may be required for careful dissection (Figure 1 ). See Box 1 for tissue specific details. Critical: Work quickly to minimize tissue damage from autolysis. Caution: Be careful around cutting implements and properly dispose of sharps. Use proper personal protective equipment (PPE) to reduce exposure to potential blood-or air-borne pathogens. Timing: 2 days 3) Our preferred method of fixation uses 1 ml of BD Cytofix/Cytoperm for every 3 ml of 1X pH 7.4 PBS. Please consult published methods for preparing FFPE samples 38 . Transfer thin (a few mm) tissue sections (skin, lymph node, wedge resections) to a 50 ml conical tube with 20 ml of fixative. For the bowel, completely submerge the pinned tissue in fixative. The ideal ratio of fixative to tissue is 20:1. Incubate at 4°C for 16-24 hours. Critical: Be mindful of the expiration date published on the BD Cytofix/Cytoperm bottle. If working with potentially infectious samples, identify the fixation conditions that fully inactivate pathogen(s) before preserving samples as described above. For example, an internal biosafety review committee found that increasing the incubation period to 72 hours inactivated SARS-CoV-2 virus particles in mouse lung tissues. Importantly, tissue epitopes were well preserved under these conditions. Caution: Formaldehyde is a known carcinogen and environmental hazard. Wear PPE and dispose of waste properly. 4) Wash samples twice, less than 5 minutes per wash, in 1X PBS at room temperature to remove excess fixative. 5) Place sample in 30% sucrose (wt/vol) and incubate at 4°C for 16-24 hours. 6) Fill a Histomold with OCT medium and embed the tissue. The tissue should occupy less than 60% of the mold volume. Freeze by placing the Histomold on dry ice. Using forceps, ensure the tissue is correctly oriented in the Histomold for subsequent sectioning. For orientation guidance see Box 1. 7) Wrap in foil and store at -80°C. Pause Point: Cryopreserved tissues can be left at -80°C for several years. Timing: 2.5 hours 8) Remove the tissue block from -80°C and allow it to equilibrate to the chamber temperature of the cryostat for 1 hour. 9) While blocks are equilibrating in the cryostat (1 hour), coat a 2-well chambered coverglass by pipetting 15 μl of chrome alum gelatin into each glass well. Use a pipette tip or smaller coverslip (18x18 mm) to spread the solution. Dry for 1 hour in a 60°C oven. Critical: It may require multiple passes to get an even film on the coverglass. Aspirate any large accumulations as these can form autofluorescent regions. Do not use the adhesive past the stated expiration date as tissue adherence will be compromised. 10) Prepare 20-30 μm sections with a cryostat. Section tissue directly onto the 2-well chambered coverglass. Critical: The tissue section should be completely flat and centered within the well. It is worth preparing several backup samples during each session. Caution: Be careful around cutting implements and properly dispose of sharps. Use PPE to reduce exposure to blood-or air-borne pathogens. 11) Dry sections onto coated 2-well chambered coverglass for 1 hour at 37°C or overnight at room temperature. Critical: Do not store chambered coverglass with sectioned tissue in a -20°C freezer or the tissue will lift. It is best to use the chambers within 1-2 days of preparation. Timing: 1 hour 12) For a 2-well chambered coverglass, add 1 ml of 1X PBS to each well to rehydrate the tissue. Incubate for 5 minutes at room temperature. 13) Add 400 μl of Blocking Buffer per well. Place humidity chamber with 2-well chambered coverglass into the BioWave Pro microwave directly on the cooling plate. Switch on the SteadyTemp Pro 50062 Thermoelectric Recirculating Chiller set to 26°C. Critical: Ensure the cooling plate is filled with ultrapure water, no air or bubbles are present, and the temperature probe is secured. Make sure that the SteadyTemp cooler option is activated in the software. 14) Start one cycle of the microwave program. A 2-1-2-1-2-1-2-1-2 program is used where '2' denotes 2 minutes at 100 watts and '1' denotes 1 minute at 0 watts. The above program is executed once for blocking and secondary antibody labelling and twice for primary antibody labelling. Alternatively, thin tissue sections (5-10 µm) can be immunolabeled for 1 hour at 37°C. 15) Aspirate the Blocking Buffer. 16) Add 400 μl of primary antibody solution per well. Perform two cycles of the microwave program or incubate for 1 hour at 37°C (5-10 μm sections). Critical: It is important to carefully validate and titrate all antibodies for optimal immunolabeling prior to implementation in IBEX protocols, preferably with sections of the same tissue. 17) Aspirate the antibody solution and wash with 3 exchanges of 3 ml of 1X PBS. The entire wash step can be performed in 5 minutes. 18) If a secondary antibody is to be used add this now in 400 μl of Blocking Buffer and perform one cycle in the microwave as above or incubate for 1 hour at 37°C (5-10 μm sections). Then wash with 3 exchanges of 3 ml of 1X PBS. Critical: Do not include secondary antibodies that will cross-react with primary antibodies in multiplexed panels. Always use highly cross-adsorbed secondary antibodies to prevent off-target immunolabeling. 19) Add 1 ml of Fluoromount-G to samples. Critical: It is beneficial to leave samples for 30 minutes at room temperature in the dark to allow the tissue to equilibrate and settle before imaging. Pause Point: Samples are stable in mounting media for several days at room temperature in the dark; however, we obtain the best results when images are acquired within 24 hours of immunolabeling. Timing: 4 hours 20) Clean the bottom of the chambered coverglass with lens cleaner and lens paper immediately before imaging. Add immersion oil to the glass surface and place on the microscope stage. 21) Slide the chamber firmly into the top left corner (or equivalent) of the stage insert, so the tissue will be consistently positioned in the XY plane. 22) Image on a confocal inverted microscope. We use a Leica TCS SP8 X system as outlined here. 23) Using Leica LAS X Navigator software, define the tissue volume to be acquired (number of tiles and z-stack size). Be sure to note the tile number and z-stack volume as this will be kept constant throughout all cycles. 24) To minimize spectral overlap, perform multiple scans using separate detectors with sequential laser excitation of compatible fluorophores. 25) Following image acquisition, correct for spectral overlap between fluorophores (Box 2). Timing: 30 minutes 26) Clean off immersion oil and thoroughly aspirate Fluoromount-G with a pipette. 27) Perform three exchanges of 3 mL of 1x PBS to completely dissolve and wash away the Fluoromount-G. Critical: It is imperative that all Fluoromount-G be removed for bleaching to be effective. 28) Prepare a 1 mg/mL solution of LiBH4 in diH2O. Caution: Perform these steps in a chemical hood with appropriate PPE. The reaction can generate hydrogen gas, which is flammable. To avoid flames, always work with small amounts (<10 mg) of LiBH4. Store LiBH4 in a sealed container with desiccant and use a new vial of LiBH4 no later than 4 weeks after opening original container. Critical: Leave the solution to incubate at room temperature for 10 minutes after gentle mixing. Formation of bubbles indicates the solution is ready. The solution must be used within 4 hours or it becomes ineffective. The solution can contain manufacturing impurities and should be passed through a 0.22 μm syringe filter. 29) Add the LiBH4 solution to the tissue. The tissue should be completely covered by the solution. For a chambered coverglass, we add 1 ml per well. Incubate for 10 minutes at room temperature exposed to standard ambient lighting. 30) Optional: If using BV421 and BV510 dyes, add LiBH4 to the chamber and place on the microscope stage. Turn the epifluorescence lamp to maximum power, select the DAPI filter, focus on the tissue, and scan across the acquired region of interest using the eye piece to observe signal loss (1-2 minutes per field of view). 31) Perform three exchanges of 3 mL of 1X PBS to completely wash away the LiBH4 solution. Critical: Incomplete washing can lead to bleaching of the subsequent panel of antibodies. Cycles of tissue labeling, image acquisition, and fluorophore bleaching Timing: 6 hours 32) Add the next panel of antibodies and repeat the procedure from Steps 16 to 19. 33) Extra attention is required when placing the sample back onto the microscope stage. The XY plane should be similar due to consistent positioning in the stage insert. 34) Open the image acquired from Cycle 1 in the LAS X Navigator software by right-clicking the desired image and selecting "Open in New Viewer". Scroll to the top of the z-stack (Begin) and click "Live" to view the sample presently on the microscope stage (Cycle 2, for example). Using the channel that contains the repeated marker (Hoechst), identify unique structures (nuclear shapes) that are present in the "live" image (Cycle 2, for example) and the previous image (Cycle 1). Set this z-position as your Begin. To set the End, repeat this step while preserving the total z-stack volume captured in the previous image (8 μm). 36) Image using the same parameters established for the image acquired during Cycle 1. Critical: It may be necessary to check alignment across different XY regions of the tissue. Distinctive tissue structures such as nuclei are useful to achieve fine alignment (Extended Data Figure 1c ). 37) Repeat Steps 26-31 to inactivate LiBH4-sensitive fluorophores. 38) Repeat Steps 32-36 to reach the desired number of cycles and markers. Process images using Steps 78-90. Timing: 2 hours for fixed frozen tissues (40A); 3.5 hours for FFPE tissues (40B) 39) Coat a square 22x22 mm #1.5 glass coverslip by adding 3 μl of chrome alum gelatin to one side. Spread evenly using the edge of another coverslip and dry for 30-60 minutes in a 60°C oven. Denote the coated side of the coverslip using a symbol with a StatMark pen. We always mark the lower right corner with a series of characters that can only be read in one direction (QJZ). This prevents confusion if the coverslip is reoriented over the course of the experiment (sectioning, chamber assembly). A. Fixed frozen tissue preparations I. Using a cryostat, section the OCT embedded tissue at 10 μm thickness onto the center of the coverslip and dry overnight at room temperature or for 1 hour at 37°C. Critical: Ensure the tissue section is completely flat and centered on the glass coverslip. It is worth preparing several backup samples during one session. Caution: Be careful around cutting implements and properly dispose of sharps. Use PPE to reduce exposure to blood-or air-borne pathogens. Pause Point: The dried samples can be stored (covered) at room temperature for up to 5 days before use; however, we recommend acquiring images within 1-2 days of sample preparation. B. FFPE tissue preparation I. Use a microtome to cut sections at 5 μm. Caution: Be careful around cutting implements and properly dispose of sharps. Use PPE to reduce exposure to blood-or air-borne pathogens. II. Float tissue onto coated coverslips using the same technique utilized for FFPE sections on glass slides. III. Place in a 60°C oven for 1 hour to adhere the tissues to the coverslips. IV. To deparaffinize the tissue, place coverslips in a Wash N'Dry coverslip rack. Add 100 ml of the solutions listed in (V-X) to individual jars (8 in total) of the EasyDip slide staining kit and rack. Use forceps to transfer the coverslip rack between jars. Do not allow the tissue to dry out at any stage. V. 100% Xylene for 10 minutes. VI. 100% Xylene for 10 minutes. VII. 100% Ethanol 10 minutes. VIII. 95% Ethanol for 10 minutes. IX. 70% Ethanol for 5 minutes with quick wash (< 1 minute) in water. X. 10% Formalin for 15 minutes with quick wash (< 1 minute) in water. TBST for 5 minutes. XI. For antigen retrieval, place coverslips (in Wash N'Dry coverslip rack) in a glass beaker with 100 ml of a 1X solution of AR6 buffer. Place beaker in a 95°C water bath and incubate for 40 minutes. Remove from the water bath and allow to gradually cool on the bench for at least 20 minutes. XIII. Replace 1X AR6 buffer with 1X PBS and cover glass beaker with aluminum foil. Pause Point: The samples can be stored in PBS at room temperature for up to 2 days before use. Critical: Always check the antigen retrieval conditions specified by the antibody vendor before immunolabeling as the buffer(s) suitable for one epitope may be incompatible with another epitope. For this reason, we optimize the antigen retrieval protocol to obtain conditions that work for all antibodies used in our experiments. Caution: Perform deparaffinization in a properly functioning chemical hood. Read the safety data sheets associated with these chemicals and take proper precautions before handling. Xylene and formalin (formaldehyde) are known physical and environmental hazards. Additionally, xylene and ethanol are highly flammable liquids. Timing: 45 minutes 46) PBS can be added directly from a 1X stock to the provided glass container in Reservoir 10 of the ARIA. 47) Hoechst and Blocking Solution: Add 1 μl of Hoechst 33342 and 10 μl Fc-block to 1 ml of Blocking Buffer described in Reagents section. 48) Antibody Panels: In 400 μl total volume of Blocking Buffer, prepare antibody panels for each iterative cycle using previously determined titrations. Critical: Do not include secondary antibodies that will cross-react with primary antibodies in multiplexed panels. Always use highly cross-adsorbed secondary antibodies to prevent off-target immunolabeling. 49) LiBH 4: Prepare at least 5 ml of a 0.5 mg/ml LiBH4 solution (dissolved in diH2O). Caution: Perform these steps in a chemical hood with appropriate PPE. The reaction can generate hydrogen gas which is flammable. To avoid flames, always work with small amounts (<10 mg) of LiBH4. Store LiBH4 with desiccant and use a new vial of LiBH4 no more than 4 weeks after opening the primary container. Critical: Only make this solution just before the run starts. The solution becomes less effective at bleaching and will need replacement after 4 hours. The solution can contain manufacturing impurities and must be passed through a 0.22 μm syringe filter before adding to the ARIA fluidics device. Prepare the ARIA unit Timing: 10 minutes 50) Switch on the FLPG unit and ensure a minimum of 2.2 bar is reached before switching on the ARIA unit power supply and starting the Fluigent Controller Software on the attached computer. Critical: If not already done, perform a calibration run and record the values, making sure these recorded values appear whenever the software is restarted. 51) Create a custom ARIA program based on the example steps outlined below. Load this sequence before each run. 52) Add solutions to the reservoirs specified in the program on the ARIA machine. Our standard configuration is: LiBH 4 (Reservoir 1), Hoechst + Fc block (Reservoir 2), Antibody Panels (Reservoir 3-8), and PBS (Reservoir 10). Critical: Only 15 ml Falcon™ brand tubes fit the taper to ensure an airtight seal. Example ARIA Sequence Program for a 6 cycle experiment (Total time: ~630 minutes (10.5 hours) Step Step Initial setup of the THUNDER microscope Timing: 5 minutes 53) Switch on microscope and LED8 source. Launch LAS X software. Select objective (this protocol is optimized for a 40x/1.30 oil immersion objective). Place the camera into 16-bit mode in the configuration tab. Select the required channels based on the fluorophores present in antibody panels. Set LED power to 25% with 150 ms exposure time for all. Critical: If using an AF750 filter combination, increase LED power to 40% for this channel as the signal is greatly reduced with the AFC function. 54) Highlight the Hoechst channel and turn on the Linked Shading feature. Follow the command prompts using the Leica THUNDER dialog box to set this for each objective on first use. 55) The LAS X Dye Separation module may be used to compensate for spectral spillover between channels. See Box 2 for details. Critical: Following system priming, the imaging chamber will start to fill. Check there are no leaks. If air is not completely removed from the chamber during filling, loosen the stage insert and gently tilt so air bubbles rise to the outlet channel. Timing: 10 minutes 67) Wait for the Fluigent software to reach the programmed pause step. By this point the imaging chamber will be filled, the tissue will be rehydrated, and nuclear staining with Hoechst 33342 will be complete. 68) In the LAS X software, click the "Live" button to visualize the Hoechst staining and bring the center of the tissue into sharp focus. 69) Click on the "Show Highspeed Autofocus Panel" then from the Focus-system dropdown choose "Adaptive Focus Control". Check "AFC on/off" box so it is active. Choose 'Continuous mode' and AFC mode 'Quality'. Critical: The green light should appear and hold position remain stable. If this fails, adjust the focus up and down. Intermittent flickering is acceptable. 70) Set up THUNDER deconvolution. Recommended parameters are to use the ICC setting with RI set to 1.33. Strength is set to 98% and Feature size is best set to 2000 nm for membrane markers or 3000 nm for nuclear markers in our experience. 71) Switch on the 'Timecourse' tab and set the number of cycles to match that of the microfluidics program. 72) Enter Navigator mode, map the tissue using the spiral function and create the region of interest for acquisition by tiling. 73) While in Navigator select the triggering module. 74) With the 'ARIA to Leica' dropdown selected, check "Trigger linked to acquisition" then the check box next to tile number in the Regions Box. In the Channels tab select 'First Channel only', in the Timelapse tab select "Every cycle" and in the Stage tab select "At positions 1" 75) Switch to the 'Leica to ARIA' dropdown and check "Use in experiment." Set number of pulses to 1 and to a 100 ms duration. Check the box next to tile number in the Regions box then set the dropdown from Trigger to "After acquisition." In the Channels tab, type the total number of channels being acquired in the "At Channel Number" box. We recommend manually removing air bubbles every 4 cycles. This can be done by placing a 31G tuberculin syringe in the secondary inlet port (See Figure 2b) and aspirating while PBS is injected into the imaging chamber. Critical: Replace the LiBH4 after 4 hours of use as its activity diminishes with time. A manual pause can be programmed into the Fluigent software. The ideal workflow is to start the automated IBEX protocol early in the workday. This allows for the replacement of LiBH4 and bubble removal to be completed before leaving at the end of the day, allowing the system to complete overnight. 77) When the cycle is complete the file can be saved and processed with Steps 78-90. Thoroughly clean the RC-21B chamber after each use to remove vacuum grease. Immerse in distilled water to dissolve any precipitated PBS crystals. Image post-processing Timing: 45 minutes 78) We use commercially available Imaris software (Imaris x64 9.5.0) for processing raw images. Use the Imaris File Converter x64 9.5.0 software to transform the Leica confocal microscope output .lif files into .ims files. 79) If using the automated IBEX protocol, iterative images are included as different timepoints of the same image, e.g., timepoint 1 corresponds to cycle 1 image, timepoint 2 corresponds to cycle 2 image, and so on. To obtain individual images (antibody panel 1 from cycle 1, antibody panel 2 from cycle 2) for downstream registration, go to Edit>Crop Time and select from "1" to "1" for timepoint 1 and save using a name with details related to its acquisition, e.g. human_liver_panel1 or human_liver_cycle1. Open the Imaris file with all the timepoints and repeat these steps for each cycle using from "2" to "2" to obtain the timepoint 2 image and so on. 80) For each imaging round, edit the file in Imaris and apply any desired processing steps such as image smoothing, channel naming, and channel pseudo-coloring. Channel thresholding and background subtraction can be performed using the Image Processing tools in Imaris to eliminate signal from autofluorescence or left-over signal from incomplete fluorophore inactivation. 81) The SimpleITK registration software requires use of a consistent naming strategy. Channels should be uniformly named as prefix-separator character-postfix. Example: "Panel1 CD3_AF594" with space as a separator character for the channel where an anti-CD3 Alexa Fluor 594 antibody was used in the first panel. See help file provided with extension and [https://niaid.github.io/imaris_extensions/XTRegisterSameChannel.html] for further details. 82) Perform image registration using Simple ITK for either manual (3D with z-stack) or automated (2D single z-slice) IBEX. 83) Launch the software. Click Imaris Extensions > Simple ITK > Affine Registration of z-stack using common channel. 84) One .ims file for each panel of the entire multiplex experiment should be uploaded using the Browse button next to File names. Enter the Channel name prefix separator character. If using the example above, this will be a single space. Click next. 85) Select the registration channel. This will be the common named channel used as the fiducial marker, e.g., Hoechst. Select the 'Fixed Image', usually the image file from cycle 1, to which other images will be registered. Select the desired directory under 'Output file'. The 'Start registration at resolution' option is usually set to the maximal resolution to give the best registration possible. Reduce this if computational power is limited. Click 'Register' to begin. 86) After successful completion of the first step, the 'Resample and Save Combined Image' button will become available. Click and wait for the progress bar to complete. 87) There is a final option to generate a correlation matrix as a PDF for quantitative assessment of the registration. Check the channel box and then click 'Compute Correlations Before and After Registration'. 88) Open the output file in Imaris. The registered image of all panels with channel information should be present and is now ready for further analysis or publication. 89) Be patient when opening the registered file for the first time. It can take 20-30 minutes to view a typical 6 cycle 20 GB dataset. 90) Immediately save the file after initial opening to speed up subsequent viewing. Individual tissues must be prepared differently to ensure correct orientation and preservation during sectioning. For the tissues highlighted in Figure 1 , use the following approaches. a. Bowel: First, pour 4% molten agarose (wt/vol) dissolved in PBS into 6 well plates, covering each well with 1-1.5 ml of agarose. Allow to harden for 20 minutes. Open the bowel-opposite the mesentery or a given lesion of interest-along its entire length using scissors. Once open, rinse any residual fecal material from the mucosal surface using a stream of PBS. Cut thin strips from the opened bowel, spanning from the mucosa to the serosa, as shown in Figure 1 . Pin the bowel flat onto the hardened agarose surface using 30G needles and immediately proceed to tissue processing. b. Skin: These samples often curl and are difficult to orient. Shape into 1 cm x 1 cm x 3-5 mm squares and immediately proceed to tissue processing. c. Lymph nodes: Carefully remove excess perinodal fat with fine forceps. Small gastric lymph nodes can be kept whole, but large lymph nodes should be cut at 2-3 mm intervals perpendicular to the longest plane. d. Wedge resections (liver, kidney, spleen): Cut specimens into thin sections (less than 3-5 mm in thickness). e. Other tissues: Consult with a pathologist and the emerging Common Coordinate Framework 36 to enable relating the processed image data to tissue anatomy. Use the suggestions above for sample preparation to maintain physical integrity and effective, rapid fixation. 2. Tissue Orientation in OCT medium a. Bowel: Use a dissecting microscope and light source to aid in orienting the tissue for a longitudinal cross section. b. Skin: Position appropriately for a complete cross section perpendicular to the surface of the tissue. c. Lymph nodes: Orient to obtain sections along the sagittal plane. d. Wedge resections (liver, kidney, spleen): Identify the smooth capsule and position the sample to allow sections perpendicular to this surface. Dye separation is an approach to separate fluorochromes with overlapping fluorescence spectra in multiplexed experiments, so the signals can be correctly ascribed to the markers they originate from. We recommend using the Channel Dye Separation module of the Leica LAS X software. If Leica LAS X software is not available, use an open-source alternative for spectral unmixing, e.g. ImageJ plugins 52,53 (https://www.youtube.com/watch?v=W90qs0J29v8). 1. Begin by creating single color controls using reference antibodies conjugated to the same fluorophores present in IBEX tissue panels, e.g., Hoechst, CD20 AF488, CD21 AF532, CD31 PE, CD3 iF594, CD163 AF647, Ki-67 AF700). 2. Acquire single labeled tissue sections (e.g., CD20 AF488 or CD31 PE) using the same acquisition parameters employed for IBEX imaging. 3. Following acquisition of single-color control images, perform Channel Dye Separation in the LAS X Dye Separation module by selecting reference regions corresponding to positive signal for each channel (e.g., 7 channels in the above example). 4. Apply the unmixing "matrix" to all images using the Automatic Dye Separation algorithm of the Leica LAS X software. This tool uses a cluster-based analysis algorithm to vectorize the gray levels within the image and separate them into clusters for removal of crosstalk. Incomplete fluorophore inactivation resulting in leftover signal in subsequent cycle High antibody concentration for an abundant marker Use properly titrated antibodies, place dim markers in earlier cycles, increase duration of fluorophore inactivation to 20 minutes for secondary antibodies used in automated IBEX protocol, and, if needed, threshold dim signal using image processing software post-acquisition. 25 Both IBEX methods generate high quality, multiplexed imaging data with the following attributes based on the acquisition settings described here: i) image resolution of 0.284 (manual) or 0.160 µm (automated) in x-y, ii) 8-bit (manual) or 16-bit (automated) dynamic range, iii) tiled regions of interest >9 mm 2 , and iv) total time for an equivalent 24-plex dataset of 26 (manual, 4 cycle, 8 µm z-stack) or 14 hours (automated, 6 cycle, single z-slice). These properties are distinguishing, as other imaging modalities may require 27 hours to acquire a 1 mm 2 area at a resolution of 0.260 µm 16 . We provide here representative datasets obtained using the manual IBEX method for a wide range of human tissues including the mesenteric lymph node (38-plex, 9 cycles), spleen (25-plex, 4 cycles), and liver (22-plex, 4 cycles) ( Figure 3 ). Using the automated IBEX protocol, the following human fixed frozen tissues were profiled: mesenteric lymph node (24-plex, 6 cycles), jejunum (24-plex, 6 cycles), and skin (19-plex, 5 cycles), a very challenging tissue due to its delicate structure and high background autofluorescence (Figure 4a-c) . Additionally, we demonstrate an application of the automated IBEX method for imaging human kidney FFPE tissues (16-plex, 5 cycles) (Figure 4d) . Importantly, the cycle and marker numbers presented here are provided as a proof-of-concept and do not represent a technical limitation (see Radtke et al., for IBEX imaging exceeding 65 parameters 23 ). Cell-cell alignment across imaging cycles is typical and, importantly, needed for visualizing and quantifying complex cell types in situ as phenotypic markers are frequently distributed over multiple cycles. IBEX-generated images are compatible with established methods for analyzing high dimensional imaging data including the open source, computational histology topography cytometry analysis toolbox (histoCAT) 54 , as previously demonstrated 23 . (a) The automated IBEX protocol uses a compact microfluidics system that delivers multiple solutions to an imaging chamber placed on an inverted microscope stage. Fluids are pushed through the system with an air compressor unit and delivered to the imaging chamber based on signals coordinated by the chip (2-switch). The inverted microscope and fluidics device send and receive TTL pulses using precise timings established by interfaced control software. (b) Samples are sectioned onto coated coverslips and assembled into a closed bath imaging chamber. Following assembly, the imaging chamber is secured to a magnetic platform and mounted onto the microscope stage. Schematic demonstrates the multiple components of the overall sample preparation from top (1) to bottom (5) . Fluid (purple shading) enters the chamber via the perfusion inlet port, collects in the bath, and exits by the perfusion outlet port that is attached to a vacuum line (not pictured). (c) Automated IBEX consists of: 1) nuclear labeling with Hoechst, 2) antibody labeling for 1 hour at 37°C using a heated microscope stage, 3) imaging region(s) of interest, 4) bleaching with LiBH4, and 5) repeating steps 2-4 until the desired number of parameters is achieved, typically 12 hours for a 6 cycle, 25-plex experiment. Adams, D. L., Alpaugh, R. K., Tsai, S., Tang Extended Data Figure 1 . Critical steps in the manual IBEX protocol. Extended Data Figure 2 . Equipment and assembly of imaging chamber for automated IBEX protocol. Table S1 . Time and method used to bleach fluorescently conjugated antibodies and dyes. Table S2 . IBEX panels for human organs. Table S3 . Recommendations for optimal antibody and fluorophore pairing for IBEX panel design. Table S4 . Estimated costs for IBEX implementation. Tables S1-S4 The human body at cellular resolution: the NIH Human Biomolecular Atlas Program Anatomical Structures, Cell Types, and Biomarkers Tables Plus 3D Reference Organs in Support of a Human Reference Atlas. bioRxiv Analyzing proteome topology and function by automated multidimensional fluorescence microscopy Topological proteomics, toponomics, MELK-technology Highly multiplexed single-cell analysis of formalin-fixed, paraffinembedded cancer tissue Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging Immuno-SABER enables highly multiplexed and amplified protein imaging in tissues Multiplexed ion beam imaging of human breast tumors Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy Multiplexed Epitope-Based Tissue Imaging for Discovery and Healthcare Applications Spatial mapping of protein composition and tissue organization: a primer for multiplexed antibody-based imaging Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging The single-cell pathology landscape of breast cancer IBEX: A versatile multiplex optical imaging approach for deep phenotyping and spatial analysis of cells in complex tissues Commensal-driven immune zonation of the liver promotes host defence The Design of SimpleITK SimpleITK Image-Analysis Notebooks: a Collaborative Environment for Education and Reproducible Research Ultrabright photoactivatable fluorophores created by reductive caging Multiplex Staining by Sequential Immunostaining and Antibody Removal on Routine Tissue Sections Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM) The effect of mild alkali and alkaline borohydride on the carbohydrate and peptide moieties of fetuin Production of Fc fragments of IgM Fluorescence Methods for the Histochemical Demonstration of Monoamines. 3. Sodium Borohydride Reduction of the Fluorescent Compounds as a Specificity Test Lithium Borohydride as a Reducing Agent Surgical Pathology Dissection: An Illustrated Guide Toward a Common Coordinate Framework for the Human Body Manual of Surgical Pathology (Surgical Pathology) Optimized RNA extraction from non-deparaffinized, laser-microdissected material Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism The Chemoattractant Receptor Ebi2 Drives Intranodal Naive CD4(+) T Cell Peripheralization to Promote Effective Adaptive Immunity Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies Spatial distribution and function of T follicular regulatory cells in human lymph nodes Lymph-node resident CD8alpha+ dendritic cells capture antigens from migratory malaria sporozoites and induce CD8+ T cell responses National Cancer Institute's, H. I. The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities Proteomics. Tissue-based map of the human proteome Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging A pyramid approach to subpixel registration based on intensity Estimated costs for IBEX implementation. Tissue Grossing and Processing • Reagents and consumables for 100 samples <$ • Tools for embedding/processing for 100 samples <$1 Leica CM1950) or equivalent, available in most core facilities ~$ Leica, RM2255) or equivalent, available in most core facilities <$20,000 • Stereomicroscope and illuminator <$ Manual and Automated IBEX Immunolabeling and microscopy • Leica TCS SP8 X confocal microscope or equivalent, highly variable $500 Pro microwave and SteadyTemp Pro, optional (incubate at 37°C) ~$31 4 per antibody per run (2 µg in 400 µl), scales with complexity of panels and number of samples Manual IBEX Immunolabeling and microscopy • Leica THUNDER microscope or equivalent • Additional accessories (triggering cables) <$100 • ~$4 per antibody per run (2 µg in 400 µl), scales with complexity of panels and number of samples Automated IBEX Software and system requirements for image processing • Imaris and Imaris File Converter (x64, version 9.5.0), variable depending on bulk pricing and bundling with other licenses • System requirements for image processing, highly variable $4,000-30,000 o MacBook Pro 2.3 GHz 8-Core i9 with 32 GB memory $4,000, scaled to multiple nodes on a highperformance cluster (>$5,000 per node) for batch processing o HP Z8 G4 Workstation or equivalent Manual and Automated IBEX We would like to thank Robert Pelletier and Mark Aruda from Fluigent for their sterling assistance with the ARIA fluidics device. We are extremely grateful for the technical support provided by George Portugal, Emily Cox, and Ed Buck from Harvard Apparatus. We thank Dr. Stefania Pittaluga for her assistance with tissue grossing and orientation. We are appreciative of Drs. Giorgio Cattoretti and Maddalena Bolognesi for sharing their insights on fluorophore inactivation with sodium borohydride. Joshua Croteau is an employee of Biolegend, Inc. and James Marr is an employee of Leica Microsystems, Inc. Please see original IBEX publication for additional panels including the following mouse tissues: lymph node, spleen, thymus, lung, small intestine, and liver: https://doi.org/10.1073/pnas.2018488117.